2-甲基-5-硝基-1-咪唑丙酸 | 16935-04-9

• 分子结构分类: 有机化合物 - 有机杂环化合物 - 唑类
• 中文名称: 2-甲基-5-硝基-1-咪唑丙酸
• 英文名称: 1-<2-Carboxyethyl>-2-methyl-4-nitro-imidazol
• 英文别名: 3-(2-methyl-4-nitro-1-imidazolyl)propionic acid；2-methyl-4-nitro-1-imidazolepropionic acid；3-(2-methyl-4-nitro-imidazol-1-yl)-propionic acid；3-(2-methyl-4-nitro-1H-imidazol-1-yl)propanoic acid；3-(2-methyl-4-nitroimidazol-1-yl)propanoic acid
• CAS: 16935-04-9
• 化学式: C₇H₉N₃O₄
• mdl: MFCD00134515
• 分子量: 199.166
• InChiKey: QIJTUXYFQLHGJI-UHFFFAOYSA-N

物化性质

• 沸点：
  476.4±25.0 °C(Predicted)
• 密度：
  1.51±0.1 g/cm3(Predicted)

计算性质

• 辛醇/水分配系数(LogP)：
  -0.4
• 重原子数：
  14
• 可旋转键数：
  3
• 环数：
  1.0
• sp3杂化的碳原子比例：
  0.428
• 拓扑面积：
  101
• 氢给体数：
  1
• 氢受体数：
  5

反应信息

• 作为反应物：
  描述：

  2-甲基-5-硝基-1-咪唑丙酸 在 溴 、 potassium hydrogencarbonate 作用下， 以 N,N-二甲基甲酰胺 为溶剂， 反应 3.0h， 以95%的产率得到3-(5-Bromo-2-methyl-4-nitro-imidazol-1-yl)-propionic acid
  参考文献：
  名称：

  A new high-yielding method for the preparation of 2-alkyl- and 1,2-dialkyl-4-nitro-5-bromoimidazoles

  摘要：

  DOI：

  10.1021/jo00037a051
• 作为产物：
  描述：

  丙烯酸 、 2-甲基-4-硝基咪唑 在 吡啶 作用下， 以 二甲基亚砜 为溶剂， 以91%的产率得到2-甲基-5-硝基-1-咪唑丙酸
  参考文献：
  名称：

  N-Substitution of 2-methyl-4(5)-nitro-1H-imidazole: a new, high-yield method for preparation of 4-nitro isomers

  摘要：

  DOI：

  10.1021/jo00298a070

文献信息

• [EN] MELANIN-CONCENTRATING HORMONE RECEPTOR ANTAGONISTS AND METHODS OF USE<br/>[FR] ANTAGONISTES VIS-A-VIS DU RECEPTEUR D'HORMONE DE MELANO-CONCENTRATION (MCH), ET PROCEDES D'UTILISATION
  申请人：UNIV CALIFORNIA

  公开号：WO2005094817A1

  公开（公告）日：2005-10-13

  This invention relates generally to methods and compositions useable to a) block or antagonize melanin-concentrating hormone (MCH) receptors and/or b) decrease food intake or c) treat a disorder such as obesity, a metabolic disorder, an eating disorder, depression or urinary incontinence. Compositios of this invention include N-benzylamino cyclic thioureas, pharmaceutical preparations containing them, and their use as antagonists of (MCH receptor) and/or for other therapeutic or diagnostic purposes.

  本发明涉及一般用于a）阻止或拮抗黑色素浓集激素（MCH）受体和/或b）降低食物摄入或c）治疗肥胖症、代谢紊乱、进食障碍、抑郁症或尿失禁等疾病的方法和组合物。本发明的组合物包括N-苄基氨基环硫脲、含有它们的制药制剂以及它们作为（MCH受体）拮抗剂和/或其他治疗或诊断目的的用途。
• Substituted diaryl heterocycles, process for their preparation and their use as medicaments
  申请人：Aventis Pharma Deutschland GmbH

  公开号：US20040132752A1

  公开（公告）日：2004-07-08

  This invention discloses and claims diary heterocycles of formula (I) 1 and their pharmaceutically acceptable salts, pharmaceutical compositions thereof, and methods of using said compounds of formula (I) for the treatment or prevention of excessive weight or obesity, and for treatment of Type II diabetes, arteriosclerosis, high blood pressure, depression, anxiety, anxiety neuroses, and schizophrenia. Methods for treatment of excessive weight or obesity and for treatment of Type II diabetes with a mixture of a compound of formula I and antiobesity agents or appetite-regulating active ingredients, or with a mixture of a compound of formula I and antidiabetics or hypoglycemic active ingredients are also disclosed and claimed.

  本发明公开和声明了式（I）1的日记杂环及其药学上可接受的盐、制药组合物以及使用式（I）化合物治疗或预防过度体重或肥胖、治疗II型糖尿病、动脉硬化、高血压、抑郁症、焦虑症、焦虑神经症和精神分裂症的方法。还公开和声明了使用式I化合物与抗肥胖药物或食欲调节活性成分混合物或与抗糖尿病药物或降血糖活性成分混合物治疗过度体重或肥胖和治疗II型糖尿病的方法。
• Metal complexes as radiosensitizers: Cobalt(II), copper(II), rhodium(II) and platinum(II) complexes of 3-(1-imidazoyl)propionic acid and some nitro-substituted derivatives, and the crystal structure and radiosensitizer activity of [CuL2(H2O)]2 · 2H2O, where LH = 3-[1-(4-nitroimidazoyl)]propionic acid
  作者：David M.L. Goodgame、Christopher J. Page、David J. Williams、Ian J. Stratford

  DOI：10.1016/s0277-5387(00)83571-8

  日期：1992.1

  The preparations are reported of 3-[1-(4-nitroimidazoyl)]propionic acid, 3-[1-(2-methyl-4-nitroimidazoyl)]propionic acid and 3-[1-(2-nitroimidazoyl)]propionic acid, and also of some cobalt(II), copper(II), rhodium(II) and platinum(II) complexes with these ligands or with 3-[1-imidazoyl]propionic acid. The complexes were characterized by spectroscopic methods, and the compound [CuL2(H2O)]2.2H2O, where LH = 3-[1-(4-nitroimidazoyl)]propionic acid, was shown by X-ray diffraction to be dinuclear with each of the organic ligands bonded to two copper(II) ions via the carboxylate groups. Radiosensitization studies on [CuL2(H2O)]2.2H2O using hypoxic Chinese hamster V79 cells gave enhancement ratios similar to those for misonidazole, and significantly greater than those for typical, uncomplexed 4-nitroimidazoles.
• TOPOLOGICALLY SEGREGATED, ENCODED SOLID PHASE LIBRARIES
  申请人：SELECTIDE CORPORATION

  公开号：EP0705279B1

  公开（公告）日：2003-02-19
• SALTS OF PAROXETINE
  申请人：SMITHKLINE BEECHAM PLC

  公开号：EP1091958A1

  公开（公告）日：2001-04-18